Works matching AU Colombel, J. ‐ F.

Results: 88

Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis.

Published in:

American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 4, p. 771, doi. 10.1038/ajg.2011.62

By:

Leblanc, S.;
Allez, M.;
Seksik, P.;
Flourié, B.;
Peeters, H.;
Dupas, J. L.;
Bouguen, G.;
Peyrin-Biroulet, L.;
Duclos, B.;
Bourreille, A.;
Dewit, O.;
Bouhnik, Y.;
Michetti, P.;
Chaussade, S.;
Saussure, P.;
Mary, J. Y.;
Colombel, J. F.;
Lémann, M.

Publication type:

Article

TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort.

Published in:

American Journal of Gastroenterology (Springer Nature), 2009, v. 104, n. 2, p. 384, doi. 10.1038/ajg.2008.36

By:

Thiébaut, R;
Kotti, S;
Jung, C;
Merlin, F;
Colombel, J F;
Lemann, M;
Almer, S;
Tysk, C;
O'Morain, M;
Gassull, M;
Binder, V;
Finkel, Y;
Pascoe, L;
Hugot, J-P

Publication type:

Article

Activated Eosinophils in Inflammatory Bowel Disease: Do They Matter?

Published in:

1999

By:

Desreumaux, P.;
Nutten, S.;
Colombel, J. F.

Publication type:

Editorial

Significance of Interleukin-1β and Interleukin-1 Receptor Antagonist Genetic Polymorphism in Inflammatory Bowel Diseases.

Published in:

American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 7, p. 1164

By:

Heresbach, D.;
Alizadeh, M.;
Dabadie, A.;
Le Berre, N.;
Colombel, J. F.;
Yaouanq, J.;
Bretagne, J. F.;
Semana, G.

Publication type:

Article

Hepatic Steatosis Revealing Celiac Disease: A Case Complicated by Transitory Liver Failure.

Published in:

1996

By:

Cassagnou, M.;
Boruchowicz, A.;
Guillemot, F.;
Gheyssens, Y.;
Cortot, A.;
Colombel, J. F.;
Devisme, L.

Publication type:

Letter

Association of an Attack of Varicella and an Achalasia.

Published in:

1995

By:

Castex, F.;
Guillemot, F.;
Talbodec, N.;
Colombel, J. F.;
Paris, J. C.;
Cortot, A.

Publication type:

Letter

Remission of Myasthenia Gravis after Proctocolectomy in a Patient with Ulcerative Colitis.

Published in:

1993

By:

Gower-Rousseau, C.;
Reumaux, D.;
Bellard, M.;
Delecourt, L.;
Ribet, M.;
Colombel, J. F.

Publication type:

Letter

Hidradenitis Suppurativa and Crohn's Disease in Two Families: A Significant Association?

Published in:

1992

By:

Gower-Rousseau, C.;
Maunoury, V.;
Colombel, J. F.;
Coulom, P.;
Piette, F.;
Cortot, A.;
Paris, J. C.

Publication type:

Letter

Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD).

Published in:

Clinical & Experimental Immunology, 2000, v. 122, n. 2, p. 180, doi. 10.1046/j.1365-2249.2000.01364.x

By:

Brandt, E.;
Colombel, J.-F.;
Ectors, N.;
Gambiez, L.;
Emilie, D.;
Geboes, K.;
Capron, M.;
Desreumaux, P.

Publication type:

Article

Effect of intrajejunal elemental diet perfusion on local secretion of soluble CD4 and CD8.

Published in:

Clinical & Experimental Immunology, 1996, v. 104, n. 2, p. 293, doi. 10.1046/j.1365-2249.1996.28734.x

By:

Desreumaux, P.;
Levy, A.;
Vaerman, J. P.;
Capron, M.;
Cortot, A.;
Colombel, J. F.

Publication type:

Article

Secretion of immunoglobulins and plasma proteins from the colonic mucosa: an in vivo study in man.

Published in:

Clinical & Experimental Immunology, 1995, v. 99, n. 2, p. 221

By:

Prigent-Delecourt, L.;
Coffin, B.;
Colombel, J. F.;
Dehennin, J. P.;
Vaerman, J. P.;
Rambaud, J. C.

Publication type:

Article

Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced <em>in vivo</em> secretion of secretory IgA.

Published in:

Clinical & Experimental Immunology, 1990, v. 80, n. 2, p. 196

By:

Marteau, P.;
Colombel, J. F.;
Nemeth, J.;
Vaerman, J. P.;
Dive, J. C.;
Rambaud, J. C.

Publication type:

Article

Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

Published in:

Clinical & Experimental Immunology, 1988, v. 74, n. 3, p. 404

By:

Torpier, G.;
Colombel, J. F.;
Chandelier, C. Mathieu;
Capron, M.;
Dessaint, J. P.;
Cortot, A.;
Paris, J. C.;
Capron, A.

Publication type:

Article

Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 1, p. 65, doi. 10.1111/apt.14794

By:

Sandborn, W. J.;
Rutgeerts, P.;
Gasink, C.;
Jacobstein, D.;
Zou, B.;
Johanns, J.;
Sands, B. E.;
Hanauer, S. B.;
Targan, S.;
Ghosh, S.;
de Villiers, W. J. S.;
Colombel, J.‐F.;
Feagan, B. G.

Publication type:

Article

Systematic review: safety of mesalazine in ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 12, p. 1597, doi. 10.1111/apt.14688

By:

Sehgal, P.;
Colombel, J.‐F.;
Aboubakr, A.;
Narula, N.

Publication type:

Article

Editorial: de novo inflammatory bowel disease following bariatric surgery—potential implications for research and clinical practice. Authors’ reply.

Published in:

2018

By:

Ungaro, R.;
Colombel, J.‐F.

Publication type:

Editorial

Bariatric surgery is associated with increased risk of new‐onset inflammatory bowel disease: case series and national database study.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 8, p. 1126, doi. 10.1111/apt.14569

By:

Ungaro, R.;
Fausel, R.;
Chang, H. L.;
Chang, S.;
Chen, L. A.;
Nakad, A.;
El Nawar, A.;
Prytz Berset, I.;
Axelrad, J.;
Lawlor, G.;
Atreja, A.;
Roque Ramos, L.;
Torres, J.;
Colombel, J.‐F.

Publication type:

Article

Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 896, doi. 10.1111/apt.14550

By:

Barré, A.;
Colombel, J.‐F.;
Ungaro, R.

Publication type:

Article

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications.

Published in:

2018

By:

Côté‐Daigneault, J.;
Luong, M. L.;
Colombel, J.‐F.;
Peerani, F.

Publication type:

Letter to the Editor

Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 219, doi. 10.1111/apt.14420

By:

Colombel, J.‐F.;
Sandborn, W. J.;
Reinisch, W.;
Peyrin‐Biroulet, L.;
Panaccione, R.;
Rutgeerts, P.;
Hanauer, S. B.;
Ghosh, S.;
Van Assche, G.;
Robinson, A. M.;
Lau, W.;
Maa, J.‐F.;
Huang, B.;
Pappalardo, B.;
Read, H.

Publication type:

Article

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 2, p. 142, doi. 10.1111/apt.14106

By:

Roblin, X.;
Boschetti, G.;
Williet, N.;
Nancey, S.;
Marotte, H.;
Berger, A.;
Phelip, J. M.;
Peyrin‐Biroulet, L.;
Colombel, J. F.;
Del Tedesco, E.;
Paul, S.;
Flourie, B.

Publication type:

Article

Editorial: biologics in inflammatory bowel disease-time for direct comparisons.

Published in:

2017

By:

Ungaro, R. C.;
Colombel, J.‐F.

Publication type:

Editorial

Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 12, p. 1481, doi. 10.1111/apt.14063

By:

Roda, G.;
Narula, N.;
Pinotti, R.;
Skamnelos, A.;
Katsanos, K. H.;
Ungaro, R.;
Burisch, J.;
Torres, J.;
Colombel, J.‐F.

Publication type:

Article

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 6, p. 801, doi. 10.1111/apt.13948

By:

Vuitton, L.;
Peyrin‐Biroulet, L.;
Colombel, J. F.;
Pariente, B.;
Pineton de Chambrun, G.;
Walsh, A. J.;
Panes, J.;
Travis, S. P. L.;
Mary, J. Y.;
Marteau, P.

Publication type:

Article

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 4, p. 533, doi. 10.1111/apt.13897

By:

Carrat, F.;
Seksik, P.;
Colombel, J.‐F.;
Peyrin‐Biroulet, L.;
Beaugerie, L.;
Colombel, Jean‐Frédéric;
Cosnes, Jacques;
Gendre, Jean‐Pierre;
Lémann, Marc;
Hébuterne, Xavier;
Cortot, Antoine;
Bouhnik, Yoram;
Laharie, David;
Dupas, Jean Louis;
Flourié, Bernard;
Lerebours, Eric;
Beaugerie, Laurent;
Peyrin‐Biroulet, Laurent;
Allez, Matthieu;
Messing, Bernard

Publication type:

Article

Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 2, p. 264, doi. 10.1111/apt.13852

By:

Feagan, B. G.;
Patel, H.;
Colombel, J.‐F.;
Rubin, D. T.;
James, A.;
Mody, R.;
Lasch, K.

Publication type:

Article

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 50, doi. 10.1111/apt.13838

By:

Colombel, J.‐F.;
Jharap, B.;
Sandborn, W. J.;
Feagan, B.;
Peyrin‐Biroulet, L.;
Eichner, S. F.;
Robinson, A. M.;
Mostafa, N. M.;
Zhou, Q.;
Thakkar, R. B.

Publication type:

Article

Editorial: serologic microbial associated markers to predict Crohn's disease behaviour - authors' reply.

Published in:

2016

By:

Colombel, J.‐F.;
Riddle, M. S.;
Murray, J. A.

Publication type:

Editorial

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis.

Published in:

Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 12, p. 1300, doi. 10.1111/apt.13641

By:

Choung, R. S.;
Princen, F.;
Stockfisch, T. P.;
Torres, J.;
Maue, A. C.;
Porter, C. K.;
Leon, F.;
De Vroey, B.;
Singh, S.;
Riddle, M. S.;
Murray, J. A.;
Colombel, J. F.;
Riddle, Mark S.;
Porter, Chad K.;
Laird, Renee M.;
Gutierrez, Ramiro L.;
Chapman, Vicky P.;
Colombel, Jean‐Frederic;
Torres, Joana;
Murray, Joseph A.

Publication type:

Article

Letter: mucosal healing is associated with improved long-term outcomes in Crohn's disease - authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 12, p. 1347, doi. 10.1111/apt.13637

By:

Shah, S. C.;
Colombel, J.‐F.;
Sands, B. E.;
Narula, N.

Publication type:

Article

The features of mucosa-associated microbiota in primary sclerosing cholangitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 7, p. 790, doi. 10.1111/apt.13552

By:

Torres, J.;
Bao, X.;
Goel, A.;
Colombel, J.‐F.;
Pekow, J.;
Jabri, B.;
Williams, K.M.;
Castillo, A.;
Odin, J.A.;
Meckel, K.;
Fasihuddin, F.;
Peter, I.;
Itzkowitz, S.;
Hu, J.

Publication type:

Article

Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 3, p. 317, doi. 10.1111/apt.13475

By:

Shah, S. C.;
Colombel, J.‐F.;
Sands, B. E.;
Narula, N.

Publication type:

Article

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Published in:

Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 2, p. 252, doi. 10.1111/apt.13466

By:

Bourrier, A.;
Carrat, F.;
Colombel, J.‐F.;
Bouvier, A.‐M.;
Abitbol, V.;
Marteau, P.;
Cosnes, J.;
Simon, T.;
Peyrin‐Biroulet, L.;
Beaugerie, L.;
Gendre, Jean‐Pierre;
Lémann, Marc;
Hébuterne, Xavier;
Cortot, Antoine;
Bouhnik, Yoram;
Laharie, David;
Dupas, Jean Louis;
Flourié, Bernard;
Lerebours, Eric;
Allez, Matthieu

Publication type:

Article

Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 9, p. 1082, doi. 10.1111/apt.13387

By:

Jharap, B.;
Sandborn, W. J.;
Reinisch, W.;
D'Haens, G.;
Robinson, A. M.;
Wang, W.;
Huang, B.;
Lazar, A.;
Thakkar, R. B.;
Colombel, J.‐F.

Publication type:

Article

Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 5, p. 504, doi. 10.1111/apt.13291

By:

Rutgeerts, P.;
Feagan, B. G.;
Marano, C. W.;
Padgett, L.;
Strauss, R.;
Johanns, J.;
Adedokun, O. J.;
Guzzo, C.;
Zhang, H.;
Colombel, J.‐F.;
Reinisch, W.;
Gibson, P. R.;
Sandborn, W. J.

Publication type:

Article

Review article: non-malignant oral manifestations in inflammatory bowel diseases.

Published in:

Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 1, p. 40, doi. 10.1111/apt.13217

By:

Katsanos, K. H.;
Torres, J.;
Roda, G.;
Brygo, A.;
Delaporte, E.;
Colombel, J.‐F.

Publication type:

Article

Editorial: post hoc analysis of SONIC trial - authors' reply.

Published in:

2015

By:

Colombel, J.‐F.;
Cornillie, F.;
Bevelander, G.

Publication type:

Editorial

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.

Published in:

Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 8, p. 734, doi. 10.1111/apt.13139

By:

Colombel, J.‐F.;
Reinisch, W.;
Mantzaris, G. J.;
Kornbluth, A.;
Rutgeerts, P.;
Tang, K. L.;
Oortwijn, A.;
Bevelander, G. S.;
Cornillie, F. J.;
Sandborn, W. J.

Publication type:

Article

Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.

Published in:

Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 10, p. 1171, doi. 10.1111/apt.12976

By:

Ho, T. H.;
Cohen, B. L.;
Colombel, J.‐F.;
Mehandru, S.

Publication type:

Article

Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 5, p. 486, doi. 10.1111/apt.12863

By:

Wolf, D.;
D'Haens, G.;
Sandborn, W. J.;
Colombel, J.‐F.;
Van Assche, G.;
Robinson, A. M.;
Lazar, A.;
Zhou, Q.;
Petersson, J.;
Thakkar, R. B.

Publication type:

Article

Factors associated with pregnancy outcome in anti- TNF treated women with inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 4, p. 363, doi. 10.1111/apt.12833

By:

Seirafi, M.;
Vroey, B.;
Amiot, A.;
Seksik, P.;
Roblin, X.;
Allez, M.;
Peyrin‐Biroulet, L.;
Marteau, P.;
Cadiot, G.;
Laharie, D.;
Boureille, A.;
De Vos, M.;
Savoye, G.;
Rahier, J.‐F.;
Carbonnel, F.;
Bonaz, B.;
Colombel, J.‐F.;
Bouhnik, Y.

Publication type:

Article

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 10, p. 1236, doi. 10.1111/apt.12499

By:

Panaccione, R.;
Colombel, J.‐F.;
Sandborn, W. J.;
D'Haens, G.;
Zhou, Q.;
Pollack, P. F.;
Thakkar, R. B.;
Robinson, A. M.

Publication type:

Article

Systematic review: fertility in non-surgically treated inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 8, p. 847, doi. 10.1111/apt.12478

By:

Tavernier, N.;
Fumery, M.;
Peyrin‐Biroulet, L.;
Colombel, J.‐F.;
Gower‐Rousseau, C.

Publication type:

Article

Review article: the role of anti-TNF in the management of ulcerative colitis - past, present and future.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 9, p. 855, doi. 10.1111/apt.12284

By:

Danese, S.;
Colombel, J.‐F.;
Peyrin‐Biroulet, L.;
Rutgeerts, P.;
Reinisch, W.

Publication type:

Article

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 4, p. 438, doi. 10.1111/apt.12187

By:

Allen, P. B.;
Kamm, M. A.;
Peyrin ‐ Biroulet, L.;
Studd, C.;
Mc Dowell, C.;
Allen, B. C. M.;
Connell, W. R.;
Cruz, P. P.;
Bell, S. J.;
Elliot, R. P.;
Brown, S.;
Desmond, P. V.;
Lemann, M.;
Colombel, J. ‐ F.

Publication type:

Article

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 2, p. 204, doi. 10.1111/apt.12145

By:

Sandborn, W. J.;
Colombel, J.‐F.;
D'Haens, G.;
Van Assche, G.;
Wolf, D.;
Kron, M.;
Lazar, A.;
Robinson, A. M.;
Yang, M.;
Chao, J. D.;
Thakkar, R.

Publication type:

Article

Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 5, p. 533, doi. 10.1111/j.1365-2036.2011.04759.x

By:

Rahier, J.‐F.;
De Beauce, S.;
Dubuquoy, L.;
Erdual, E.;
Colombel, J.‐F.;
Jouret‐Mourin, A.;
Geboes, K.;
Desreumaux, P.

Publication type:

Article

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 5, p. 497, doi. 10.1111/j.1365-2036.2011.04753.x

By:

Torres, J.;
de Chambrun, G. Pineton;
Itzkowitz, S.;
Sachar, D. B.;
Colombel, J.‐F.

Publication type:

Article

Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 306, doi. 10.1111/j.1365-2036.2011.04717.x

By:

Kamm, M. A.;
Hanauer, S. B.;
Panaccione, R.;
Colombel, J.‐F.;
Sandborn, W. J.;
Pollack, P. F.;
Zhou, Q.;
Robinson, A. M.

Publication type:

Article

The changing epidemiology of paediatric inflammatory bowel disease: authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 12, p. 1381, doi. 10.1111/j.1365-2036.2011.04676.x

By:

Chouraki, V.;
Turck, D.;
Colombel, J.‐F.;
Gower‐Rousseau, C.

Publication type:

Article